Format

Send to:

Choose Destination
See comment in PubMed Commons below
Hered Cancer Clin Pract. 2007 Sep 15;5(3):164-79. doi: 10.1186/1897-4287-5-3-164.

Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin.

Author information

  • 1Katedra Patologii, Pomorska Akademia Medyczna, Szczecin. sekrpato@sci.pam.szczecin.pl

Abstract

Epidemiologic research conducted over the last two decades has led us to believe that inherited factors play an important role in the aetiology of prostate cancer, but the genes which underlie the inherited susceptibility are elusive. The most compelling associations to date are with genes involved in DNA damage repair, including BRCA2. In Poland we have initiated a programme to identify DNA variants which confer an increased risk of prostate cancer and other cancers. Here we review our recent results. We found that germline mutations in BRCA1, CHEK2 and NBS1 confer an increased prostate cancer risk in Polish men. We provide evidence that CHEK2 is a multi-organ cancer susceptibility gene. We show that inherited variation in RNASEL and MSR1 genes do not contribute to prostate cancer development in Poland.

PMID:
19725994
[PubMed]
PMCID:
PMC2736990
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk